Novel PET imaging methods for prostate cancer.
Esther MenaPeter C BlackSoroush Rais-BahramiMichael GorinMohamad AllafPeter ChoykePublished in: World journal of urology (2020)
Among the available PET agents for prostate cancer, PSMA PET has emerged as the leader. It is likely to have great impact on the diagnosis, staging and management of prostate cancer patients.